These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 12704643

  • 1. Synchronized prostate cancer cells for studying androgen regulated events in cell cycle progression from G1 into S phase.
    Cifuentes E, Croxen R, Menon M, Barrack ER, Reddy GP.
    J Cell Physiol; 2003 Jun; 195(3):337-45. PubMed ID: 12704643
    [Abstract] [Full Text] [Related]

  • 2. Resveratrol induces prostate cancer cell entry into s phase and inhibits DNA synthesis.
    Kuwajerwala N, Cifuentes E, Gautam S, Menon M, Barrack ER, Reddy GP.
    Cancer Res; 2002 May 01; 62(9):2488-92. PubMed ID: 11980638
    [Abstract] [Full Text] [Related]

  • 3. Differential requirements for ras and the retinoblastoma tumor suppressor protein in the androgen dependence of prostatic adenocarcinoma cells.
    Fribourg AF, Knudsen KE, Strobeck MW, Lindhorst CM, Knudsen ES.
    Cell Growth Differ; 2000 Jul 01; 11(7):361-72. PubMed ID: 10939590
    [Abstract] [Full Text] [Related]

  • 4. Involvement of p27Kip1 in G1 arrest by high dose 5 alpha-dihydrotestosterone in LNCaP human prostate cancer cells.
    Tsihlias J, Zhang W, Bhattacharya N, Flanagan M, Klotz L, Slingerland J.
    Oncogene; 2000 Feb 03; 19(5):670-9. PubMed ID: 10698512
    [Abstract] [Full Text] [Related]

  • 5. Progression of LNCaP prostate tumor cells during androgen deprivation: hormone-independent growth, repression of proliferation by androgen, and role for p27Kip1 in androgen-induced cell cycle arrest.
    Kokontis JM, Hay N, Liao S.
    Mol Endocrinol; 1998 Jul 03; 12(7):941-53. PubMed ID: 9658399
    [Abstract] [Full Text] [Related]

  • 6. Androgen receptor regulates Cdc6 in synchronized LNCaP cells progressing from G1 to S phase.
    Bai VU, Cifuentes E, Menon M, Barrack ER, Reddy GP.
    J Cell Physiol; 2005 Aug 03; 204(2):381-7. PubMed ID: 15887248
    [Abstract] [Full Text] [Related]

  • 7. Differential modulation of G1-S-phase cyclin-dependent kinase 2/cyclin complexes occurs during the acquisition of a polyploid DNA content.
    Datta NS, Williams JL, Long MW.
    Cell Growth Differ; 1998 Aug 03; 9(8):639-50. PubMed ID: 9716181
    [Abstract] [Full Text] [Related]

  • 8. Lycopene inhibition of cell cycle progression in breast and endometrial cancer cells is associated with reduction in cyclin D levels and retention of p27(Kip1) in the cyclin E-cdk2 complexes.
    Nahum A, Hirsch K, Danilenko M, Watts CK, Prall OW, Levy J, Sharoni Y.
    Oncogene; 2001 Jun 07; 20(26):3428-36. PubMed ID: 11423993
    [Abstract] [Full Text] [Related]

  • 9. [Detection of cell cycle related gene expression in cultured immortalized human lens epithelial cell].
    Wu M, Li S, Zeng J, Gao J, Liu Y.
    Zhonghua Yan Ke Za Zhi; 2002 Jun 07; 38(6):367-71. PubMed ID: 12139816
    [Abstract] [Full Text] [Related]

  • 10. Indole-3-carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells.
    Chinni SR, Li Y, Upadhyay S, Koppolu PK, Sarkar FH.
    Oncogene; 2001 May 24; 20(23):2927-36. PubMed ID: 11420705
    [Abstract] [Full Text] [Related]

  • 11. Deregulation of the Rho GTPase, Rac1, suppresses cyclin-dependent kinase inhibitor p21(CIP1) levels in androgen-independent human prostate cancer cells.
    Knight-Krajewski S, Welsh CF, Liu Y, Lyons LS, Faysal JM, Yang ES, Burnstein KL.
    Oncogene; 2004 Jul 15; 23(32):5513-22. PubMed ID: 15077174
    [Abstract] [Full Text] [Related]

  • 12. A flavonoid antioxidant, silymarin, inhibits activation of erbB1 signaling and induces cyclin-dependent kinase inhibitors, G1 arrest, and anticarcinogenic effects in human prostate carcinoma DU145 cells.
    Zi X, Grasso AW, Kung HJ, Agarwal R.
    Cancer Res; 1998 May 01; 58(9):1920-9. PubMed ID: 9581834
    [Abstract] [Full Text] [Related]

  • 13. Cyclin E-cdk2 activation is associated with cell cycle arrest and inhibition of DNA replication induced by the thymidylate synthase inhibitor Tomudex.
    Yin MB, Guo B, Panadero A, Frank C, Wrzosek C, Slocum HK, Rustum YM.
    Exp Cell Res; 1999 Feb 25; 247(1):189-99. PubMed ID: 10047461
    [Abstract] [Full Text] [Related]

  • 14. Androgen receptor regulation of G1 cyclin and cyclin-dependent kinase function in the CWR22 human prostate cancer xenograft.
    Gregory CW, Johnson RT, Presnell SC, Mohler JL, French FS.
    J Androl; 2001 Feb 25; 22(4):537-48. PubMed ID: 11451350
    [Abstract] [Full Text] [Related]

  • 15. Lactoferrin inhibits G1 cyclin-dependent kinases during growth arrest of human breast carcinoma cells.
    Damiens E, El Yazidi I, Mazurier J, Duthille I, Spik G, Boilly-Marer Y.
    J Cell Biochem; 1999 Sep 01; 74(3):486-98. PubMed ID: 10412049
    [Abstract] [Full Text] [Related]

  • 16. Cell cycle arrest induced by the vitamin D(3) analog EB1089 in NCI-H929 myeloma cells is associated with induction of the cyclin-dependent kinase inhibitor p27.
    Park WH, Seol JG, Kim ES, Jung CW, Lee CC, Binderup L, Koeffler HP, Kim BK, Lee YY.
    Exp Cell Res; 2000 Feb 01; 254(2):279-86. PubMed ID: 10640426
    [Abstract] [Full Text] [Related]

  • 17. Hyperoxia induces S-phase cell-cycle arrest and p21(Cip1/Waf1)-independent Cdk2 inhibition in human carcinoma T47D-H3 cells.
    Bilodeau JF, Faure R, Piedboeuf B, Mirault ME.
    Exp Cell Res; 2000 May 01; 256(2):347-57. PubMed ID: 10772807
    [Abstract] [Full Text] [Related]

  • 18. Regulation of androgen-dependent prostatic cancer cell growth: androgen regulation of CDK2, CDK4, and CKI p16 genes.
    Lu S, Tsai SY, Tsai MJ.
    Cancer Res; 1997 Oct 15; 57(20):4511-6. PubMed ID: 9377562
    [Abstract] [Full Text] [Related]

  • 19. IFNalpha induces the expression of the cyclin-dependent kinase inhibitor p21 in human prostate cancer cells.
    Hobeika AC, Subramaniam PS, Johnson HM.
    Oncogene; 1997 Mar 13; 14(10):1165-70. PubMed ID: 9121765
    [Abstract] [Full Text] [Related]

  • 20. BMP signals inhibit proliferation and in vivo tumor growth of androgen-insensitive prostate carcinoma cells.
    Miyazaki H, Watabe T, Kitamura T, Miyazono K.
    Oncogene; 2004 Dec 16; 23(58):9326-35. PubMed ID: 15531927
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.